SEC Form D · filed June 27, 2017
Nacuity Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Charles M. Lieser · Fort Worth, TXExecWilliam H. Conner · Fort Worth, TXExec · DirectorG. M. Wall, Ph.D · Fort Worth, TXExecDavid J. Wohlberg · Los Angeles, CADirectorRichard M. Chin, M.D · San Francisco, CADirectorDr. Gerald D. Cagle · Fort Worth, TXDirectorIsaac M. Blech · New York, NYDirectorSanford J. Hillsberg · Portland, ORDirectorLewis C. Pell · Santa Clara, CAExecJamie M. Yoakum · Tampa, FLDirectorAndrew W. Midler · Santa Clara, CADirectorJohn M. Nehra · Minneapolis, MNDirectorSeth Levine · New York, NYExec · DirectorMartin Devenney · Milpitas, CAExecTodd M. Sakow · Tampa, FLDirectorMichael A. Seton · Tampa, FLDirectorMike Weber · Uniondale, NYExec · DirectorChris Hopkins · Richmond, British Columbia, CanadaExecGreg B. Gibson · Richmond, British Columbia, CanadaDirectorLucas Stoioff · Chicago, ILDirectorDavid Rekhson · Chicago, ILExecErik D. Hagen · Oakbrook Terrace, ILDirectorJason J. Hagen · Oakbrook Terrace, ILDirectorTome J. Tomaj · Oakbrook Terrace, ILDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗